Margetuximab: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

27 April 2025

  • curprev 16:1416:14, 27 April 2025 Alara E. Dagsali talk contribs 21,662 bytes +21,662 Created page with "{{DrugProjectFormSinglePage |authorTag= Alara Ece Dagsali, M.D. |genericName=margetuximab |aOrAn=a |drugClass=HER2/neu receptor antagonist |indicationType=treatment |indication=of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease |hasBlackBoxWarning=Yes |adverseReactions='''Left Ventricular Dysfunction''' '''Embryo-Fetal Toxicity''' '''Infusio..."
Retrieved from "https://www.wikidoc.org/index.php/Margetuximab"